Kura Oncology Announces Clinical Collaboration to Evaluate Tipifarnib in Combination with …,

Phase 1/2 KURRENT trial of tipifarnib plus alpelisib expected to initiate in 2H 2021 –. SAN DIEGO, July 06, 2021 (GLOBE NEWSWIRE) — Kura …, Phase 1/2 KURRENT trial of tipifarnib plus alpelisib expected to initiate in 2H 2021 –. SAN DIEGO, July 06, 2021 (GLOBE NEWSWIRE) — Kura …, Read More

Scroll to Top